Browse funding opportunities and notices that NINR leads or supports. You may also subscribe to our funding newsletter to receive the latest funding opportunities from NINR in your email inbox.
- Learn about NIH's grant programs and their associated activity codes.
- See the NIH Guide for Grants and Contracts for all NIH funding opportunities.
Find Grant Funding
Displaying 76 - 100 of 482 results
Title | NOFO/Notice Number | Release Date | Expiration Date | Activity Code |
---|---|---|---|---|
Centers for AIDS Research (P30 Clinical Trial Not Allowed) | PAR-23-116 | P30 | ||
Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed) | PAR-23-117 | P30 | ||
Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed) | PAR-23-117 | P30 | ||
Centers for AIDS Research (P30 Clinical Trial Not Allowed) | PAR-23-116 | P30 | ||
Request for Information (RFI): Future Directions in Violence Against Women Research | NOT-NR-23-008 | |||
Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional) | PAR-23-112 | R01 | ||
Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional) | PAR-23-112 | R01 | ||
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) | PA-23-048 | T32 | ||
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) | PA-23-048 | T32 | ||
Notice of Special Interest (NOSI): Firearm Injury and Mortality Prevention Research | NOT-OD-23-039 | R01, R34, R21, U24, R61/R33, UG3/UH3 | ||
Notice of Clarification for the Funding Opportunity Description in PAR-22-230 "NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R01 Clinical Trial Optional)" | NOT-NR-23-006 | |||
Notice of Clarification for the Funding Opportunity Description in PAR-22-231 "NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R21 Clinical Trial Optional)" | NOT-NR-23-007 | |||
Notice of Change to Key Dates for PAR-22-230 NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R01 Clinical Trial Optional) | NOT-NR-23-004 | |||
Notice of Change to Key Dates for PAR-22-231 NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R21 Clinical Trial Optional) | NOT-NR-23-005 | |||
Notice of Special Interest: Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars | NOT-OD-23-031 | 333 | ||
Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards | NOT-OD-23-032 | 333 | ||
Notice of NINR Participation in RFA-OD-22-015, "Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education (R25 Clinical Trial Not Allowed) | NOT-NR-23-002 | |||
Notice of NINR Participation in NOT-EB-21-001 "Notice of Special Interest (NOSI): Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health" | NOT-NR-23-003 | |||
The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) | RFA-OD-22-028 | R01 | ||
NOTICE OF NINR TECHNICAL ASSISTANCE WEBINAR FOR RFA-NR-23-001 | NOT-NR-23-001 | |||
Notice of Special Interest (NOSI): Implementation Science to Advance Maternal Health and Maternal Health Equity for the IMPROVE initiative | NOT-HD-22-043 | R03, R21, R01 | ||
NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R01 Clinical Trial Optional) | PAR-22-230 | R01 | ||
NINR Areas of Emphasis for Research to Optimize Health and Advance Health Equity (R21 Clinical Trial Optional) | PAR-22-231 | R21 | ||
Notice of Special Interest (NOSI): Development and Preliminary Testing of Health-related Behavioral Interventions | NOT-OD-22-203 | R01, R34, R21, UG3/UH3, R61/R33, U54, U01, R21/R33 | ||
Time-Sensitive Opportunities for Health Research (R61/R33 Clinical Trial Not Allowed) | PAR-22-233 | R61/R33 |